Complex regulation of tau exon 10, whose missplicing causes frontotemporal dementia

Journal of Neurochemistry

Volumn 74, Issue 2, 2000, Pages 490-500

  Gao, Qing Sheng ^e   Memmott, John ^e   Lafyatis, Robert ^a   Stamm, Stefan ^b   Screaton, Gavin ^c   Andreadis, Athena ^d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e NONE

Author keywords

Expression pattern of regulated isoforms; Frontotemporal dementia; Microtubule binding domain; Microtubule associated protein tau; Regulation of alternative splicing

Indexed keywords

DNA; RNA; TAU PROTEIN;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENHANCER REGION; EXON; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SILENCER GENE;

ANIMALS; COS CELLS; DEMENTIA; DNA, RECOMBINANT; EXONS; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; INTRONS; TAU PROTEINS; TUMOR CELLS, CULTURED;

EID: 0033978622     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.740490.x     Document Type: Article

References (88)

1. Amendt B. A., Si Z. H., and Stoltzfus C. M. (1995) Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Mol. Cell. Biol 15, 4606-4615.
2. Andreadis A., Brown W. M., and Kosik K. (1992) Structure and novel exons of the human tau gene. Biochemistry 31, 10626-10633.
3. Andreadis A., Nisson P., Kosik K. S., and Watkins P. (1993) The exon trapping assay partly discriminates against alternatively spliced exons. Nucleic Acids Res. 21, 2217-2221.
4. Andreadis A., Broderick J. A., and Kosik K. S. (1995) Relative exon affinities and suboptimal splice site signals lead to non-equivalence of two cassette exons. Nucleic Acids Res. 23, 3585-3593.
5. Barbeaux S., Niaudet P., Gubler M. C., Grunfeld J. P., Jaubert F., Kuttenn F., Fekete C. N., Soueleyreau-Therville N., Thibaud E., Fellous M., and McElreavey K. (1997) Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat. Genet. 17, 467-470.
6. Berget S. M. (1995) Exon recognition in vertebrate splicing. J. Biol. Chem. 270, 2411-2414.
7. 35S label as an aid to rapid DNA sequence determination. Proc. Natl. Acad. Sci. USA 80, 3963-3965.
8. Binder L. I., Frankfurter A., and Rebhun L. I. (1986) The distribution of tau in the mammalian central nervous system. J. Cell Biol. 101, 1371-1378.
9. Black D. L. (1995) Finding splice sites within a wilderness of RNA. RNA 1, 763-771.
10. Black M. M., Slaughter T., Moshiah S., Obrocka M., and Fischer I. (1996) Tau is enriched on dynamic microtubules in the distal region of growing axons. J. Neurosci. 16, 3601-3619.
11. Brandt R., Léger J., and Lee G. (1995) Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J. Cell Biol. 131, 1327-1340.
12. Buckanovich R. J. and Darnell R. B. (1997) The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo. Mol. Cell. Biol. 17, 3194-3201.
13. Cáceres J. F., Misteli T., Screaton G. R., Spector D. L., and Krainer A. R. (1997) Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity. J. Cell Biol. 138, 225-238.
14. Caputi M., Casari G., Guenzi S., Tagliabue R., Sidoli A., Mello C. A., and Baralle F. E. (1994) A novel bipartite splicing enhancer modulates the differential processing of the human fibronectin EDA exon. 1994. Nucleic Acids Res. 22, 1018-1022.
15. Chabot B. (1996) Directing alternative splicing: cast and scenarios. Trends Genet. 12, 472-478.
16. Chabot B., Blanchette M., Lapierre I., and La Branche H. (1997) An intron element modulating 5′ splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1. Mol. Cell. Biol. 17, 1776-1786.
17. Chan R. C. and Black D. L. (1995) Conserved intron elements repress splicing of a neuron-specific src exon in vitro. Mol. Cell. Biol. 15, 6377-6385.
18. Clark L. N., Poorkaj P., Wszolek Z., Geschwind D. H., Nasreddine Z. S., Miller B., Li D., Payami H., Awert F., Markopoulou K., Andreadis A., D'Souza I., Lee V. M., Reed L., Trojanowski J. Q., Zhukareva V., Bird T., Schellenberg G., and Wilhelmsen K. C. (1998) Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc. Natl. Acad. Sci. USA 95, 13103-13107.
19. Couchie D., Mavilia C., Georgieff I. S., Liem R. K. H., Shelanski M. L., and Nuñez J. (1992) Primary structure of high molecular weight tau present in the peripheral nervous system. Proc. Natl. Acad. Sci. USA 89, 4378-4381.
20. Del Gatto F., Gesnel M.-C., and Breathnach R. (1996) The exon sequence TAGG can inhibit splicing. Nucleic Acids Res. 24, 2017-2021.
21. Del Gatto F., Plet A., Gesnel M.-C., Fort C., and Breathnach R. (1997) Multiple interdependent sequence elements control splicing of a fibroblast growth factor receptor 2 alternative exon. Mol. Cell. Biol. 17, 5106-5116.
22. Del Gatto-Konczak F., Olive M., Gesnel M. C., and Breathnach R. (1999) hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer. Mol. Cell. Biol. 19, 251-260.
23. Denhez F. and Lafyatis R. (1994) Conservation of regulated alternative splicing and identification of functional domains in vertebrate homologs to the Drosophila splicing regulator, suppressor-of-white-apricot. J. Biol. Chem. 269, 16170-16179.
24. Devereux J. R., Haeberli P., and Smithies O. (1984) A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12, 387-395.
25. DiTella M., Feiguin F., Morfini G., and Cáceres A. (1994) Microfilament-associated growth cone component depends upon tau for its intracellular localization. Cell Motil. Cytoskeleton 29, 117-130.
26. Drubin D. G., Kobayashi S., Kellogg D., and Kirschner M. (1988) Regulation of microtubule protein levels during cellular morphogenesis in nerve growth factor-treated PC12 cells. J. Cell Biol. 106, 1583-1591.
27. D'Souza I., Poorkaj P., Hong M., Nochlin D., Lee V. M., Bird T. D., and Schellenberg G. D. (1999) Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc. Natl. Acad. Sci. USA 96, 5598-5603.
28. Gallego M. E. and Nadal-Ginard B. (1990) Myosin light chain 1/3 gene alternative splicing: cis regulation is based upon a hierarchical compatibility between splice sites. Mol. Cell. Biol. 10, 2133-2144.
29. Goedert M., Spillantini M. G., Jakes R., Rutherford D., and Crowther R. A. (1989a) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519-526.
30. Goedert M., Spillantini M. G., Potier M. C., Ulrich J., and Crowther R. A. (1989b) Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein isoforms in human brain. EMBO J. 8, 393-399.
31. Goedert M., Spillantini M. G., and Crowther R. A. (1992) Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system. Proc. Natl. Acad. Sci. USA 89, 1983-1987.
32. Goedert M., Crowther R. A., and Spillantini M. G. (1998) Tau mutations cause frontotemporal dementia. Neuron 21, 955-958.
33. Grabowski P. J. (1998) Splicing regulation in neurons: tinkering with cell-specific control. Cell 92, 709-712.
34. Grover A., Houlden H., Baker M., Adamson J., Lewis J., Prihar G., Pickering-Brown S., Duff K., and Hutton M. (1999) 5′ splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. J. Biol. Chem. 274, 15134-15143.
35. Guo W. and Helfman D. M. (1993) cis-elements involved in alternative splicing in the rat beta-tropomyosin gene: the 3′-splice site of the skeletal muscle exon 7 is the major site of blockage in nonmuscle cells. Nucleic Acids Res. 21, 4762-4768.
36. Hasegawa M., Smith M. J., Iijima M., Tabira T., and Goedert M. (1998) Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett. 437, 207-210.
37. Hasegawa M., Smith M. J., Iijima M., Tabira T., and Goedert M. (1999) FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10. FEBS Lett. 443, 93-96.
38. Himmler A. (1989) Structure of the bovine tau gene: alternatively spaced transcripts generate a gene family. Mol. Cell. Biol. 9, 1389-1396.
39. Himmler A., Drechsel D., Kirschner M. W., and Martin D. W. (1989) Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains. Mol. Cell. Biol. 9, 1381-1388.
40. Huh G. S. and Hynes R. O. (1993) Elements regulating an alternatively spliced exon of the rat fibronectin gene. Mol. Cell. Biol. 13, 5301-5314.
41. Huh G. S. and Hynes R. O. (1994) Regulation of alternative pre-mRNA splicing by a novel repeated hexanucleotide element. Genes Dev. 8, 1561-1574.
42. Hutton M., Lendon C. L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R. C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J. M., Nowotny P., Che L. K., Norton J., Morris J. C., Reed L. A., Trojanowski J., Basun H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dodd P., Hayward N., Kwok J. B. J., Schofield P. R., Andreadis A., Snowden J., Craufurd D., Neary D., Owen F., Oostra B. A., Hardy J., Goate A., van Swieten J., Mann D., Lynch T. M., and Heutink P. (1998) Association of missense and 5′ splice site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705.
43. Kawamoto S. (1996) Neuron-specific alternative splicing of nonmuscle myosin II heavy chain B pre-mRNA requires a cis-acting intron sequence. J. Biol. Chem. 271, 17613-17616.
44. Kempf M., Clement A., Faissner A., Lee G., and Brandt R. (1996) Tau binds to the distal axon early in development of polarity in a microtubule-and microfilament-dependent manner. J. Neurosci. 16, 5583-5592.
45. Klamt B., Koziell A., Poulat F., Wieacker P., Scambler P., Berta P., and Gessler M. (1998) Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms. Hum. Mol. Genet. 7, 709-714.
46. Kosik K. S., Orecchio L. D., Bakalis S., and Neve R. L. (1989) Developmentally regulated expression of specific tau sequences. Neuron 2, 1389-1397.
47. Krämer A. (1996) The structure and function of proteins involved in mammalian pre-mRNA splicing. Annu. Rev. Biochem. 65, 367-409.
48. Lee G., Cowan N., and Kirschner M. (1988) The primary structure of the microtubule-associated protein tau. Science 239, 285-288.
49. Lee G., Neve R. L., and Kosik K. S. (1989) The microtubule binding domain of human tau protein. Neuron 2, 1615-1624.
50. Lemaire R., Winne A., Sarkissian M., and Lafyatis R. (1999) SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation. Eur. J. Immunol. 29, 823-837.
51. Lin C. H. and Patton J. G. (1995) Regulation of alternative 3′ splice site selection by constitutive splicing factors. RNA 1, 234-245.
52. Liu H. X., Zhang M., and Krainer A. R. (1998) Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins. Genes Dev. 12, 1998-2012.
53. López A. J. (1998) Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation. Annu. Rev. Genet. 32, 279-305.
54. LoPresti P., Szuchet S., Papasozomenos S. C., Zinkowski R. P., and Binder L. I. (1995) Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes. Proc. Natl. Acad. Sci. USA 92, 10369-10373.
55. Manley J. L. and Tacke R. (1996) SR proteins and splicing control. Genes Dev. 10, 1569-1579.
56. Mayeda A., Helfman D. M., and Krainer A. R. (1993) Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF. Mol. Cell. Biol. 13, 2993-3001.
57. Min H. S., Turck C. W., Nikolic J. M., and Black D. L. (1997) A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer. Genes Dev. 11, 1023-1036.
58. Nayler O., Cap C., and Stamm S. (1998) Human transformer-2-beta gene (SFRS10): complete nucleotide sequence, chromosomal localization, and generation of a tissue-specific isoform. Genomics 53, 191-202.
59. Neve R. L., Harris R., Kosik K. S., Kurnit D. M., and Donlon T. A. (1986) Identification of cDNA clones for the human microtubule-associated protein, tau, and chromosomal location of the genes for tau and MAP2. J. Mol. Brain Res. 1, 271-280.
60. Nuñez J. and Fischer I. (1997) Microtubule-associated proteins (MAPs) in the peripheral nervous system during development and regeneration. J. Mol. Neurosci. 8, 207-222.
61. Pasquier F. and Petit H. (1997) Frontotemporal dementia: its rediscovery. Eur. Neurol. 38, 1-6.
62. Patton J. G., Mayer S. A., Tempst P., and Nadal-Ginard B. (1991) Characterization and molecular cloning of polypyrimidine tract-binding protein: a component of a complex necessary for premRNA splicing. Genes Dev. 5, 1237-1251.
63. Poorkaj P., Bird T. D., Wijsman E., Nemens E., Garruto R. M., Anderson L., Andreadis A., Wiederholt W., Raskind M., and Schellenberg G. (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43, 815-825.
64. Reed R. (1996) Initial splice-site recognition and pairing during pre-mRNA splicing. Curr. Opin. Genet. Dev. 6, 215-220.
65. Sadot E., Marx R., Barg J., Behar L., and Ginzburg I. (1994) Complete sequence of the 3′ untranslated region of tau from rat central nervous system: implications for mRNA heterogeneity. J. Mol. Biol. 241, 325-331.
66. Sambrook J., Fritsch E. F., and Maniatis T. (1989) Molecular Cloning: A Laboratory Manual, 2nd edit. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
67. Sanger F., Nicklen S., and Coulson A. R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
68. Sarkissian M., Winne A., and Lafyatis R. (1996) The mammalian homolog of suppressor-of-white-apricot regulates alternative mRNA splicing of CD45 exon 4 and fibronectin IIICS. J. Biol. Chem. 271, 31106-31114.
69. Screaton G. R., Cáceres J. F., Mayeda A., Bell M. V., Plebanski M., Jackson D. G., Bell J. I., and Krainer A. R. (1995) Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J. 14, 4336-4349.
70. Sharp P. A. (1994) Split genes and RNA splicing. Cell 77, 805-815.
71. Si Z. H., Rauch D., and Stolzfus C. M. (1998) The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly. Mol. Cell. Biol. 18, 5404-5413.
72. Smith C. W. J. and Nadal-Ginard B. (1989) Mutually exclusive splicing of α-tropomyosin exons enforced by an unusual lariat branch point location; implications for constitutive splicing. Cell 56, 749-758.
73. Smith C. W. J., Patton J. G., and Nadal-Ginard B. (1989) Alternative splicing in the control of gene expression, in Cellular and Molecular Biology of Muscle Development (Kedes L. H. and Stockdale F. E., eds), pp. 573-584. Alan R. Liss, New York.
74. Spillantini M. G. and Goedert M. (1998) Tau protein pathology in neurodegenerative diseases. Trends Neurosci. 21, 428-433.
75. Spillantini M. G., Murrell J. R., Goedert M., Farlow M. R., Klug A., and Ghetti B. (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. USA 95, 7737-7741.
76. Staffa A. and Cochrane A. (1995) Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1. Mol. Cell. Biol. 15, 4597-4605.
77. Staffa A., Acheson N. H., and Cochrane A. (1997) Novel exonic elements that modulate splicing of the human fibronectin EDA exon. J. Biol. Chem. 272, 33394-33401.
78. Stamm S., Zhang M. Q., Marr T. G., and Helfman D. M. (1994) A sequence compilation and comparison of exons that are alternatively spliced in neurons. Nucleic Acids Res. 22, 1515-1526.
79. Stamm S., Casper D., Hanson V., and Helfman D. M. (1999) Regulation of the neuron-specific exon of clathrin light chain B. Mol. Brain Res. 64, 108-118.
80. Tacke R. and Goridis C. (1991) Alternative splicing in the neural cell adhesion molecule pre-mRNA: regulation of exon 18 skipping depends on the 5′-splice site. Genes Dev. 5, 1416-1429.
81. Valcárcel J. and Gebauer F. (1997) Post-transcriptional regulation: the dawn of PTB. Curr. Biol. 7, 705-708.
82. Valcárcel J. and Green M. R. (1996) The SR protein family-pleiotropic functions in pre-mRNA splicing. Trends Biochem. Sci. 21, 296-301.
83. Valcárcel J., Gaur R. K., Singh R., and Green M. R. (1996) Interaction of U2AF65 RS region with pre-mRNA branch point and promotion of base pairing with U2 snRNA. Science 273, 1706-1709.
84. Wang Y., Loomis P. A., Zinkowski R. P., and Binder L. I. (1993) A novel tau transcript in cultured human neuroblastoma cells expressing nuclear tau. J. Cell Biol. 121, 257-267.
85. Wei M.-L. and Andreadis A. (1998) Splicing of a regulated exon reveals additional complexity in the axonal microtubule-associated protein tau. J. Neurochem. 70, 1346-1356.
86. Wilhelmsen K. C. (1998) Chromosome 17-linked dementias. Cell. Mol. Life Sci. 54, 920-924.
87. Yang X., Bani M. R., Lu S. J., Rowan S., Ben-David Y., and Chabot B. (1994) The A1 and A1B proteins of heterogeneous nuclear ribonucleoparticles modulate 5′ splice site selection in vivo. Proc. Natl. Acad. Sci. USA 91, 6924-6928.
88. Zahler A. M., Neubarger K. M., Lane W. S., and Roth M. B. (1993) Distinct functions of SR proteins in alternative pre-mRNA splicing. Science 260, 219-222.